Webinar: Symptomatic Relief for Alzheimer’s Disease

On March 15, the Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) Coalition hosted a one-hour webinar on symptomatic treatment in Alzheimer’s disease. During the program, leading experts shared their perspectives on the burden of Alzheimer’s disease symptoms on patients and their families, highlighted advances in neurobiology that relate to Alzheimer’s disease symptoms, and updated participants on recent clinical development activities to improve the treatment of Alzheimer’s disease behavioral and psychiatric symptoms.

Speakers included:

Jeffrey L. Cummings, M.D., Sc.D.
Director, Lou Ruvo Center for Brain Health
Camille and Larry Ruvo Chair for Brain Health
Cleveland Clinic

Richard Malamut, M.D.
Chief Medical Officer
Senior Vice President, Research & Development
Avanir Pharmaceuticals

Joan Amatniek, M.D., MsC
Senior Director, CNS, Global Clinical Development
Otsuka Pharmaceutical

Cynthia A. Bens (Moderator)
Vice President of Public Policy, Alliance for Aging Research
Executive Director, Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD)